Back to search

University of Minnesota

Reengineering Caspase-2 for X-ray Crystallography: Use of Novel Protein Constructs to Gain Structural Insights into Alzheimer's Disease Probe Design

Abstract

dc:description.abstract

Caspases are a family of cysteine aspartyl proteases that have important roles in cell death and inflammation. When caspases are poorly regulated these processes get disrupted, leading to disease. Caspases have been implicated in a number of diseases, including cancer, inflammatory diseases, ischemia/reperfusion-related conditions (i.e. stroke), transplant failure, and neurodegenerative diseases. Of particular interest and importance is their implication in Alzheimer’s Disease and related dementias (ADRD). Previous work from Ashe et al. has shown that Caspase-2 can cleave tau protein into fragment 𝚫tau314, which is more abundant in cognitively impaired mice than are non-cognitively impaired mice and is inversely correlated with memory loss. Knocking out Casp2 in mice lowers 𝚫tau314 levels and restores memory, suggesting Casp2 inhibition could be therapeutically beneficial. The overarching goal of this project is to develop Casp2 selective inhibitors; this dissertation will focus on the structural biology efforts made to aid in compound design. Current crystal structures of Casp2 contain only peptidic inhibitors, so information about where and how non-peptidic inhibitors bind is lacking. Challenges with peptidic drugs crossing the blood-brain-barrier are well documented, and non-peptidic scaffolds are needed to advance the field. However, while possible, it has proven difficult to improve the selectivity of compounds without structural information. Limited availability of the Casp2 enzyme posed a challenge to X-ray crystallography studies. Initially we used Casp3 to structurally analyze our inhibitors, as Casp3 crystallography was enabled in our labs. While this approach was successful in providing some information on motifs that might impart Casp2 selectivity, ultimately information on what interactions to target in Casp2 was still missing. A circularly permuted Casp2 (cpCasp2) with high expression yields was proposed as a solution, but intrinsic disorder in one of the loops (L5) prevented crystallization. Aided by modeling in AlphaFold, ten novel cpCasp2 constructs were engineered with the goal of creating stability in L5 to enable crystallization. These mutants were characterized through the use of enzymatic assays, biophysical assays, and x-ray crystallography. Molecular dynamics studies indicate that JF1cpCasp2 displays higher stability than cpCasp2 and the other mutants, meeting our goal of adding stability. Gratifyingly, this construct crystallized with the canonical Casp2 inhibitor, AcVDVAD-CHO. Co-crystals diffracted to 1.51 Å and the resulting structure confirms that the tertiary structure of JF1cpCasp2 is equivalent to Casp2. Additionally, interactions made by the inhibitor are identical in both complexes. We have used this construct to generate co-crystals with hybrid peptidomimetic inhibitors, and analysis of the structures suggest the importance of two motifs to gain Casp2 selectivity: (1) the integration of bulky substituents at P2 and (2) targeting interactions with Arg417 in the S4 pocket. Finally, we generated JF1cpCasp2 co-crystals with novel electrophilic fragments, and potential non-covalent inhibitors. Casp2 co-crystals with these types of compounds have not been reported before. Overall, the JF1cpCasp2 construct has enabled structural work in Casp2 inhibitor design that has not been possible prior to this work.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fuller, Jessica Lynn

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Fuller, Jessica Lynn. (2024). Reengineering Caspase-2 for X-ray Crystallography: Use of Novel Protein Constructs to Gain Structural Insights into Alzheimer's Disease Probe Design. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/281748.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Fuller, Jessica Lynn. Reengineering Caspase-2 for X-ray Crystallography: Use of Novel Protein Constructs to Gain Structural Insights into Alzheimer's Disease Probe Design. 2024. https://hdl.handle.net/11299/281748